Strata Skin Sciences Long-term Debt / Capital 2010-2025 | SSKN
Strata Skin Sciences long-term debt / capital from 2010 to 2025. Long-term debt / capital can be defined as a measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.009B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.605B | 59.29 |
| Hims & Hers Health (HIMS) | United States | $11.194B | 116.30 |
| Doximity (DOCS) | United States | $11.153B | 51.63 |
| Tempus AI (TEM) | United States | $10.574B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.258B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.817B | 59.65 |
| Hinge Health (HNGE) | United States | $3.642B | 0.00 |
| Privia Health (PRVA) | United States | $2.447B | 167.25 |
| Schrodinger (SDGR) | United States | $1.671B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.639B | 0.00 |
| 10x Genomics (TXG) | United States | $1.600B | 0.00 |
| Phreesia (PHR) | United States | $1.595B | 0.00 |
| Enovis (ENOV) | United States | $1.556B | 8.68 |
| Azenta (AZTA) | United States | $1.507B | 70.04 |
| Omnicell (OMCL) | United States | $1.324B | 23.35 |
| Evolent Health (EVH) | United States | $1.147B | 97.70 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.567B | 0.00 |
| Standard BioTools (LAB) | United States | $0.517B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.467B | 0.00 |
| Talkspace (TALK) | United States | $0.435B | 130.00 |
| TruBridge (TBRG) | United States | $0.336B | 745.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.274B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.229B | 0.00 |
| CapsoVision (CV) | United States | $0.204B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.173B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.158B | 0.00 |
| Pulmonx (LUNG) | United States | $0.130B | 0.00 |
| American Well (AMWL) | United States | $0.128B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.89 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.078B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |